EGFR Exon 19 Deletion Mutations and Systemic/CNS Miliary Metastasis: Clinical Correlations and Response to Therapy

Podobne knjige/članki

• Erlotinib response in a NSCLC patient with a novel compound G719D+L861R mutation in EGFR
  od: Berge, Eamon M, et al.
  Izdano: (2013)
• Squamous Cell Carcinoma of the Lung with Metastasis to the GI Tract Associated with EGFR Exon 19 Deletion
  od: Weiss, Glen J., et al.
  Izdano: (2013)
• Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinoma
  od: Dahse, R, et al.
  Izdano: (2008)
• Structural characterization of EGFR exon 19 deletion mutation using molecular dynamics simulation
  od: Tamirat, Mahlet Z., et al.
  Izdano: (2019)
• 3D radiomics predicts EGFR mutation, exon-19 deletion and exon-21 L858R mutation in lung adenocarcinoma
  od: Liu, Guixue, et al.
  Izdano: (2020)